Clinical trial

NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema

NCT00143793 · Universitätsmedizin Mannheim, Other · Completed

Key facts

NCT number NCT00143793
Title NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema
Official title Mannheim NT-proBNP Study (MANPRO) Evaluating NT-proBNP and New Biomarkers in Patients Suffering From Dyspnea and/or Peripheral Edema for the Differential Diagnosis of Congestive Heart Failure
Acronym MANPRO
Lead sponsor Universitätsmedizin Mannheim, Other
Status Completed
Study type Observational
Conditions Dyspnea, Peripheral Edema
Enrollment 400
Start date Jun 1, 2005
Primary completion Dec 1, 2018
Completion Dec 1, 2019
First posted Sep 2, 2005
Last update posted Aug 27, 2020
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies